Scarica l'app Stockscreener
28.23
0.28%
0.08
Dopo l'orario di chiusura:
28.23
Precedente Chiudi:
$28.15
Aprire:
$27.59
Volume 24 ore:
695.30K
Relative Volume:
1.42
Capitalizzazione di mercato:
$915.61M
Reddito:
$796.33M
Utile/perdita netta:
$74.95M
Rapporto P/E:
13.82
EPS:
2.0427
Flusso di cassa netto:
$329.83M
1 W Prestazione:
-4.21%
1M Prestazione:
-19.39%
6M Prestazione:
-38.35%
1 anno Prestazione:
-24.03%
Intervallo 1D:
$27.14
$28.52
Intervallo di 1 settimana:
$25.47
$29.34
Portata 52W:
$25.47
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
28.23 | 833.55M | 796.33M | 74.95M | 329.83M | 2.0427 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call - Yahoo Finance
Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock - Stock Titan
COLLEGIUM PHARMACEUTICAL INC : NEEDHAM CUTS TARGET PRICE TO $46 FROM $56 - webull.com
Can Collegium Pharmaceutical (NASDAQ:COLL) Rebound From Its Yearly Low? - Kalkine Media
Collegium Pharmaceutical Initiates $50 Million Accelerated Share Buyback with Jefferies LLC - Kalkine Media
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com India
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com Canada
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program - citybiz
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Nigeria
Collegium gains on $50M accelerated share buyback program - Seeking Alpha
Collegium Pharmaceutical to repurchase $50 million in stock - Investing.com
Collegium Pharmaceutical launches $50M accelerated share repurchase under $150M buyback program - TradingView
Collegium Announces $50 Million Accelerated Share Repurchase Program - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year LowTime to Sell? - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Shares Down 6.5%Here's What Happened - MarketBeat
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - Yahoo Finance
Collegium Pharmaceutical, Inc. Revenue Breakdown – NASDAQ:COLL - TradingView
Collegium Pharmaceutical (COLL) Stock Revenue Growth Masks Deepening Margin Squeeze - Sahm
Collegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at Wall Street Zen - marketbeat.com
Collegium Pharmaceutical (NASDAQ:COLL) Releases Earnings Results, Beats Estimates By $0.20 EPS - MarketBeat
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $43 - Moomoo
Collegium Pharmaceutical (COLL) Stock May Trade At A Discount Even After A 60% Return - simplywall.st
Piper Sandler Reiterates Neutral Rating for Collegium Pharmaceutical (NASDAQ:COLL) - MarketBeat
Is Now The Time To Put Collegium Pharmaceutical (NASDAQ:COLL) On Your Watchlist? - moomoo.com
Collegium Pharmaceutical, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:COLL) 2026-08-07 - Seeking Alpha
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Unveiling an 82.76% Potential Upside - DirectorsTalk Interviews
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 1-Year Low Following Analyst Downgrade - marketbeat.com
Collegium Pharmaceutical, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Collegium Pharmaceutical stock hits 52-week low at 30.11 USD - Investing.com
Collegium Pharmaceutical, Inc. Stock 12‑Month Price Target Cut to $51.2, Implies 43% Upside - TradingView
Needham & Company LLC Cuts Collegium Pharmaceutical (NASDAQ:COLL) Price Target to $46.00 - MarketBeat
Collegium Pharmaceutical Releases Q2 2026 Financial Results - AlphaStreet
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap DownShould You Sell? - marketbeat.com
Collegium Pharmaceutical Down Over 13%, On Track for Largest Percent Decrease Since May 2024 -- Data Talk - Moomoo
Collegium Pharmaceutical (COLL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Collegium Pharmaceutical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Collegium Pharmaceutical Q2 Earnings Call Highlights - MarketBeat
Collegium Pharmaceutical falls 13% on weak revenue guidance By Investing.com - Investing.com South Africa
Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops - Yahoo Finance
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Collegium Pharmaceutical: Q2 Earnings Snapshot - marketscreener.com
Collegium Pharmaceutical Reports Q2 2026 Results, Completes AZSTARYS Acquisition and Raises Full-Year Guidance - Quiver Quantitative
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress - Yahoo Finance
Collegium Pharmaceutical, Inc. $COLL Shares Acquired by Sei Investments Co. - MarketBeat
Collegium Pharmaceutical (COLL): Principal Global Investors discloses 5% equity stake - Stock Titan
Collegium Pharmaceutical earnings ahead after ADHD acquisition By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect - Barchart.com
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo! Finance Canada
Janus Henderson Group PLC Increases Stock Position in Collegium Pharmaceutical, Inc. $COLL - marketbeat.com
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
5.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):